按产品类型（免疫球蛋白、凝血因子浓缩物、白蛋白、蛋白酶抑制剂和其他产品）、应用（神经病学、免疫学、血液学、重症监护、肺病学、血液肿瘤学、风湿病学和其他）、加工技术（离子交换色谱、亲和色谱、冷冻保存、超滤和微滤）、模式（现代血浆分馏和传统血浆分馏）、最终用户（医院和诊所、临床研究实验室学术机构等）、分销渠道（直接招标、第三方分销等）、国家（中国、日本、韩国、澳大利亚、印度、马来西亚、泰国、新加坡和亚太地区其他地区）行业趋势和预测到 2028 年。
市场分析与洞察：亚太血浆分离市场
预计亚太血浆分馏市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 7.5%，预计到 2028 年将达到 71.118 亿美元。
血浆是一种血液成分，通过血浆置换从全血中提取，用于各种治疗和医疗应用。人血浆是多种不同蛋白质的来源，但只有少数蛋白质可用于生产治疗性血浆产品。从血浆中分离、提取和纯化这些蛋白质的过程称为分馏过程。从血浆中提取的蛋白质主要分为免疫球蛋白、凝血因子浓缩物、白蛋白、蛋白酶抑制剂等类别
亚太血浆分离市场正在增长，原因是全球呼吸系统疾病增加、患有血液相关疾病的老龄人口增加以及免疫球蛋白的使用增加等因素。需要使用血浆疗法或血浆衍生物的罕见疾病的增加也是市场增长的主要因素。研发投资的增加也使亚太血浆分离市场蓬勃发展。
这份血浆分馏市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
亚太血浆分离市场范围和市场规模
亚太血浆分馏市场，按产品类型（免疫球蛋白、凝血因子浓缩物、白蛋白、蛋白酶抑制剂和其他产品）、应用（神经病学、免疫学、血液学、重症监护、肺病学、血液肿瘤学、风湿病学等）、加工技术（离子交换色谱、亲和色谱、低温保存、超滤和微滤）、模式（现代血浆分馏和传统血浆分馏）、最终用户（医院和诊所、临床研究实验室学术机构等）、分销渠道（直接招标、第三方分销等）。各细分市场之间的增长有助于您分析利基增长领域和市场进入策略，并确定您的核心应用领域和目标市场的差异。根据产品类型，血浆分馏市场细分为免疫球蛋白、凝血因子浓缩物、白蛋白、蛋白酶抑制剂和其他产品。此外，免疫球蛋白进一步细分为静脉注射免疫球蛋白、皮下免疫球蛋白等。凝血因子浓缩物进一步细分为因子 VIII、因子 CI、血管性血友病因子、凝血酶原复合物浓缩物、纤维蛋白原浓缩物和因子 XII。2021 年，免疫球蛋白拥有最大的市场份额，原因是其具有与免疫调节作用相关的大量健康益处。
- 根据应用，血浆分离市场细分为神经病学、免疫学、血液学、重症监护、肺病学、血液肿瘤学、风湿病学等。2021 年，由于血浆蛋白在治疗免疫缺陷中的使用增加等因素，免疫学占据最大的市场份额。
- 根据加工技术，血浆分离市场细分为离子交换色谱法、亲和色谱法、低温保存、超滤和微滤。2021 年，离子交换色谱法凭借利用离子去除无机物质的高净化能力等因素占据最大的市场份额。
- 根据模式，血浆分馏市场分为现代血浆分馏和传统血浆分馏。2021 年，现代血浆分馏占据最大的市场份额，这是由于血浆分馏过程中采用了最先进的设备和生产设施等因素。
- 根据最终用户，血浆分离市场细分为医院和诊所、临床研究实验室、学术机构和其他。2021 年，由于医院提供的基础设施和医疗保健设施不断改善，以及医院中血浆分离产品的标签外使用增加，以治疗各种疾病，医院和诊所拥有最大的市场份额。
- 根据分销渠道，血浆分离市场细分为直接招标、第三方分销和其他。2021 年，直接招标占据最大的市场份额，原因是。通过从制造商到医护人员的直接招标增加分销。
亚太血浆分离市场：国家层面分析
对亚太血浆分馏市场进行了分析，并按国家、类型（生物杀虫剂、生物真菌素、生物杀线虫剂、生物除草剂和其他）、来源（微生物、生化和昆虫）、形式（干性和液体）、应用（叶面施肥、水肥一体化、土壤处理、种子处理和其他）、类别（农业和园艺）和作物提供了市场规模信息。
亚太血浆分馏市场报告涵盖的国家包括中国、日本、韩国、澳大利亚、印度、马来西亚等
由于中国对血浆的广泛益处的认识不断提高，中国在亚太血浆分馏市场中占据主导地位，拥有最高的复合年增长率。
由于血浆分离需求的增加和对人类健康的日益关注，日本在亚太血浆分离市场占据主导地位。
韩国由于人口老龄化和免疫缺陷疾病而占据市场主导地位，占有最高份额。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。
农业对血浆分离的需求不断增长
亚太血浆分馏市场还为您提供了详细的市场分析，涵盖每个国家/地区的行业增长情况，包括销售额、零部件销售额、血浆分馏技术发展的影响 以及监管情景的变化及其对血浆分馏产品市场的支持。数据涵盖 2012-2018 年的历史时期。
竞争格局和亚太血浆分离市场份额分析
亚太血浆分馏市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、印度业务、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对亚太血浆分馏市场的关注有关。
血浆分馏市场的一些主要参与者包括 SL plasma、Grifols SA、Octapharma、Kendrion SPA、BPL Inc、Sanquin、Biotest AG、LFB SA、日本血液制品组织、中国生物制品控股有限公司、Green Cross corp、上海莱士、武田药品工业有限公司、Bioproducts Laboratory Ltd、Novasep Inc、Pall corporation、Kabafusion、四川远大蜀阳制药有限公司、Bharat Serums and Vaccines Limited、SK plasma、Centurion pharma、Ntas biopharmaceuticals、Merck KgAa、Boccard 和 ADMA biologics。
全球各地的公司也推出了许多产品，这也加速了亚太血浆分馏市场的增长。
例如，
- 2020 年 4 月，Grifols 在血浆分馏市场推出了 3 毫升瓶装 Hyper RAB，这是一种狂犬病免疫球蛋白，可帮助治疗世界各地的狂犬病病例。
市场参与者的合作、合资和其他策略正在扩大公司在血浆分馏市场的影响力，这也为组织的增长速度带来了益处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PRODUCTION FACILITIES FOR BLOOD PLASMA:
4.2 SUPPLIERS OF PROCESS LINES FOR PLASMA FRACTIONATION
4.2.1 RAW MATERIAL PROCUREMENT
4.2.2 MANUFACTURING
4.2.3 MARKETING & DISTRIBUTION
4.2.4 END-USERS
5 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: REGULATORY
5.1 THE U.S.
5.2 INDIA
5.3 EUROPE
5.4 BRAZIL
5.5 SOUTH AFRICA
6 MARKET OVERVIEW
6.1 3.1 DRIVERS
6.1.1 3.1.1 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE
6.1.2 RISE IN RESPIRATORY DISEASES ACROSS THE WORLD
6.1.3 INCREASE IN AGING POPULATION WITH BLOOD-RELATED AILMENTS
6.1.4 INCREASE USAGE OF IMMUNOGLOBULIN
6.2 RESTRAINTS
6.2.1 GROWING USAGE OF RECOMBINANT PROTEIN PRODUCTS
6.2.2 STRINGENT GOVERNMENT REGULATIONS REGARDING PLASMA THERAPY
6.2.3 RISK OF QUALITY AND SAFETY
6.3 OPPORTUNITIES
6.3.1 INCREASE IN PLASMA COLLECTION CENTRES
6.3.2 UNHEALTHY LIFESTYLE POSSESS SERIOUS INFLAMMATION RISK
6.3.3 ADVANCEMENT IN TECHNOLOGIES
6.4 CHALLENGES
6.4.1 SHORTAGE OF PLASMA PROTEINS
6.4.2 HIGH COST OF PLASMA THERAPY
7 IMPACT OF COVID-19 ON THE ASIA-PACIFIC PLASMA FRACTIONATION MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 IMMUNOGLOBULINS
8.2.1 INTRAVENOUS IMMUNOGLOBULINS
8.2.2 SUBCUTANEOUS IMMUNOGLOBULINS
8.2.3 OTHER IMMUNOGLOBULINS
8.3 COAGULATION FACTOR CONCENTRATES
8.3.1 FACTOR IX
8.3.2 FACTOR VIII
8.3.3 FIBRINOGEN CONCENTRATES
8.3.4 PROTHROMBIN COMPLEX CONCENTRATE
8.3.5 VON WILLEBRAND FACTOR
8.3.6 FACTOR XIII
8.4 ALBUMIN
8.5 PROTEASE INHIBITORS
8.6 OTHER PRODUCTS
9 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 IMMUNOLOGY
9.3 HAEMATOLOGY
9.4 CRITICAL CARE
9.5 NEUROLOGY
9.6 PULMONOLOGY
9.7 HAEMATO-ONCOLOGY
9.8 RHEUMATOLOGY
9.9 OTHER APPLICATION
10 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY
10.1 OVERVIEW
10.2 ION-EXCHANGE CHROMATOGRAPHY
10.3 AFFINITY CHROMATOGRAPHY
10.4 ULTRAFILTRATION
10.5 MICROFILTRATION
10.6 CRYOPRECIPITATION
11 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY MODE
11.1 OVERVIEW
11.2 MODERN PLASMA FRACTIONATION
11.3 TRADITIONAL PLASMA FRACTIONATION
12 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 CLINICAL RESEARCH LABORATORIES
12.4 ACADEMIC INSTITUTES
12.5 OTHERS
13 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTION
13.4 OTHERS
14 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 SOUTH KOREA
14.1.4 AUSTRALIA
14.1.5 INDIA
14.1.6 MALAYSIA
14.1.7 THAILAND
14.1.8 SINGAPORE
14.1.9 PHILIPPINES
14.1.10 INDONESIA
14.1.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 CSL PLASMA
17.1.1 COMPANY SNAPSHOT
17.1.2 COMPANY SHARE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 GRIFOLS, S.A.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 OCTAPHARMA AG
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 KENDRION S.P.A
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 BAXTER
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ADMA BIOLOGICS INC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BHARAT SERUMS AND VACCINES LIMITED (BSV)
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO PRODUCTS LABORATORY LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 BIOTEST AG
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 BOCCARD
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 CENTURION İLAÇ SANAYI VE TICARET A.Ş.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 GREEN CROSS CORP.
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENTS
17.15 INTAS PHARMACEUTICAL LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 JAPAN BLOOD PRODUCTS ORGANIZATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 KABAFUSION
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 LFB SA
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 MERCK KGAA
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 NOVASEP HOLDING SAS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PALL CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SANQUIN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 SHANGHAI RAAS
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS
17.25 SK PLASMA
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC ALBUMIN IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC PROTEASE INHIBITORS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC OTHER PRODUCTS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC IMMUNOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC HAEMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC CRITICAL CARE IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC NEUROLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC PULMONOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC HAEMATO-ONCOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC RHEUMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC OTHER APPLICATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC ION-EXCHANGE CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC AFFINITY CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC ULTRAFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC MICROFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC CRYOPRECIPITATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, MODE, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC MODERN PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC TRADITIONAL PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, END USER, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC HOSPITALS & CLINICS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CLINICAL RESEARCH LABORATORIES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC ACADEMIC INSTITUTES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC DIRECT TENDERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC THIRD PARTY DISTRIBUTION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 CHINA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 46 CHINA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 47 CHINA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 CHINA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 CHINA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 50 CHINA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 51 CHINA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 CHINA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 JAPAN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 JAPAN IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 55 JAPAN COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 JAPAN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 JAPAN PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 JAPAN PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 59 JAPAN PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 JAPAN PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 62 SOUTH KOREA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 SOUTH KOREA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 67 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 69 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 70 AUSTRALIA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 71 AUSTRALIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 AUSTRALIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 74 AUSTRALIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 75 AUSTRALIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 76 AUSTRALIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 77 INDIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 78 INDIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 79 INDIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 INDIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 INDIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 INDIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 83 INDIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 INDIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 85 MALAYSIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 86 MALAYSIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 87 MALAYSIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 88 MALAYSIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 89 MALAYSIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 MALAYSIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 91 MALAYSIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 MALAYSIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 93 THAILAND PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 94 THAILAND IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 95 THAILAND COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 96 THAILAND PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 THAILAND PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 98 THAILAND PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 99 THAILAND PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 THAILAND PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 SINGAPORE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 102 SINGAPORE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 103 SINGAPORE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 104 SINGAPORE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 105 SINGAPORE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 106 SINGAPORE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 107 SINGAPORE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 108 SINGAPORE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 109 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 110 PHILIPPINES IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 111 PHILIPPINES COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 112 PHILIPPINES PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 PHILIPPINES PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 115 PHILIPPINES PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 116 PHILIPPINES PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 117 INDONESIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 118 INDONESIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 119 INDONESIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 120 INDONESIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 125 REST OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC PLASMA FRACTIONATION MARKET : VENDOR SHARE ANALYSIS
FIGURE 9 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 11 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC PLASMA FRACTIONATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 IMMUNOGLOBULINS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PLASMA FRACTIONATION MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET
FIGURE 14 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020
FIGURE 15 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION)
FIGURE 16 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, CAGR (2020-2028)
FIGURE 17 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020
FIGURE 19 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 20 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, CAGR (2020-2028)
FIGURE 21 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020
FIGURE 23 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020-2028 (USD MILLION)
FIGURE 24 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, CAGR (2020-2028)
FIGURE 25 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, 2020
FIGURE 27 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, 2020-2028 (USD MILLION)
FIGURE 28 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, CAGR (2020-2028)
FIGURE 29 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY MODE, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, 2020
FIGURE 31 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 32 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, CAGR (2020-2028)
FIGURE 33 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 35 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 36 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
FIGURE 37 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: SNAPSHOT (2020)
FIGURE 39 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY COUNTRY (2020)
FIGURE 40 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE (2021 & 2028)
FIGURE 43 ASIA-PACIFIC PLASMA FRACTIONATION MARKET: COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
